CL
RANI icon

Choreo LLC’s Rani Therapeutics RANI Stock Holding History

Choreo LLC’s Portfolio RANI Stock Details RANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11,813
Closed -$5.9K – 1651
2025
Q3 		$5.9K Hold
11,813
– – ﹤0.01% 1569
2025
Q2 		$6.07K Hold
11,813
– – ﹤0.01% 1527
2025
Q1 		$14.9K Hold
11,813
– – ﹤0.01% 1436
2024
Q4 		$16.4K Buy
+11,813
New +$24.8K ﹤0.01% 1605
2024
Q2 		– Sell
-19,813
Closed -$61.6K – 1525
2024
Q1 		$61.6K Hold
19,813
– – ﹤0.01% 654
2023
Q4 		$65.8K Hold
19,813
– – ﹤0.01% 609
2023
Q3 		$43.1K Hold
19,813
– – ﹤0.01% 459
2023
Q2 		$81.6K Sell
19,813
-5,000
-20% -$23.2K ﹤0.01% 466
2023
Q1 		$128K Buy
+24,813
New +$149K ﹤0.01% 471

Other funds holding RANI

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
SCP
SymBiosis Capital Partners Bentonville, Arkansas $52.8M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LP
Longaeva Partners Chicago, Illinois $2.7B AUM 37.16% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return

Choreo LLC's RANI Position: Q4 2025 in Review

Choreo LLC sold out of Rani Therapeutics (RANI) in Q4 2025, closing a stake of 11,813 shares — an estimated $5.9K sold.

Choreo LLC first reported a position in RANI in Q1 2023 and held it in 9 quarters. The position peaked at $128K in Q1 2023. 64 funds tracked by Wall St. Rank hold RANI as of Q4 2025.

  • Choreo LLC reported no remaining Rani Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Choreo LLC sold 11,813 Rani Therapeutics shares in Q4 2025, an estimated $5.9K.
  • Choreo LLC first reported a position in Rani Therapeutics in Q1 2023 and held it in 9 quarters.
  • Choreo LLC's Rani Therapeutics position peaked at $128K in Q1 2023.
  • 64 funds tracked by Wall St. Rank held Rani Therapeutics as of Q4 2025.

Based on Choreo LLC's 13F filing for Q4 2025, filed 23 Jan 2026.